OmniSeq company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About OmniSeq

OmniSeq seeks to provide physicians with tumor-profiling information and improve access to cancer treatment options through comprehensive molecular profiling. OmniSeq was founded in 2015 and is based in Buffalo, New York.In July 2022, OmniSeq was acquired by Labcorp. The terms of the transaction were not disclosed.

OmniSeq Headquarter Location

700 Ellicott Street

Buffalo, New York, 14203,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing OmniSeq

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OmniSeq is included in 2 Expert Collections, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

OmniSeq Patents

OmniSeq has filed 3 patents.

The 3 most popular patent topics include:

  • Cancer treatments
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date


Related Topics



Oncology, Cancer treatments, Monoclonal antibodies for tumors, Immune system, Clusters of differentiation


Application Date


Grant Date


Related Topics

Oncology, Cancer treatments, Monoclonal antibodies for tumors, Immune system, Clusters of differentiation



OmniSeq Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

OmniSeq Rank

  • When was OmniSeq founded?

    OmniSeq was founded in 2015.

  • Where is OmniSeq's headquarters?

    OmniSeq's headquarters is located at 700 Ellicott Street, Buffalo.

  • What is OmniSeq's latest funding round?

    OmniSeq's latest funding round is Acquired.

  • How much did OmniSeq raise?

    OmniSeq raised a total of $18.9M.

  • Who are the investors of OmniSeq?

    Investors of OmniSeq include LabCorp, Baseline Ventures, Roswell Park Cancer Institute and Hitachi High-Technologies Corporation.

  • Who are OmniSeq's competitors?

    Competitors of OmniSeq include Perthera.

You May Also Like

Tempus Logo

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Caris Life Sciences Logo
Caris Life Sciences

Caris Life Sciences is an Irving, Texas-based provider of molecular science that assess DNA, RNA and proteins to reveal a molecular blueprint that allows physicians and cancer patients to make precise and personalized treatment decisions.

Massive Bio Logo
Massive Bio

Massive Bio is an AI powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development.


KEW is a genomic profiling company that aims to improve cancer care. The company provides therapeutic options based on an individual patient's tumor genetic profile with CANCERPLEX, its flagship clinical product for identifying genetic variants and matching them with targeted therapies in solid tumors.

CureMatch Logo

CureMatch is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch's Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients based on their molecular tumor profile.

Perthera Logo

Perthera uses AI to analyze patient medical and molecular data to enable hospitals, physicians & advocacy groups to deliver personalized cancer care. The Perthera Platform matches patients to ranked therapeutic options to improve their clinical outcomes and allows patient data access to the key segments in the Precision Oncology market. It was founded in 2012 and is based in McLean, Virginia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.